BioArctic AB (publ)

OM:BIOA B Stock Report

Market Cap: SEK 24.8b

BioArctic Future Growth

Future criteria checks 1/6

BioArctic's revenue and earnings are forecast to decline at 4.4% and 12.6% per annum respectively. EPS is expected to decline by 7.8% per annum. Return on equity is forecast to be 29.7% in 3 years.

Key information

-12.6%

Earnings growth rate

-7.79%

EPS growth rate

Biotechs earnings growth38.3%
Revenue growth rate-4.4%
Future return on equity29.67%
Analyst coverage

Low

Last updated18 Nov 2025

Recent future growth updates

BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Nov 16
BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Feb 18
Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Recent updates

BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Nov 16
BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Revenues Not Telling The Story For BioArctic AB (publ) (STO:BIOA B) After Shares Rise 26%

Aug 14
Revenues Not Telling The Story For BioArctic AB (publ) (STO:BIOA B) After Shares Rise 26%
User avatar

Regulatory Approvals And Pipeline Progress Will Redefine Neurodegeneration Care

Regulatory approvals and upcoming diagnostics are set to accelerate Leqembi adoption, expanding access and recurring royalty revenues from an underserved and growing patient base.

BioArctic's (STO:BIOA B) Solid Profits Have Weak Fundamentals

May 29
BioArctic's (STO:BIOA B) Solid Profits Have Weak Fundamentals

Here's Why BioArctic AB (publ)'s (STO:BIOA B) CEO Compensation Is The Least Of Shareholders Concerns

May 16
Here's Why BioArctic AB (publ)'s (STO:BIOA B) CEO Compensation Is The Least Of Shareholders Concerns

Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Feb 19
Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Feb 18
Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Analysts Just Published A Bright New Outlook For BioArctic AB (publ)'s (STO:BIOA B)

Jan 31
Analysts Just Published A Bright New Outlook For BioArctic AB (publ)'s (STO:BIOA B)

Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Nov 27
Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Aug 15
Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

Apr 13
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 19
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 03
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

Dec 23
Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

Nov 12
With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Jul 21
BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

Jul 15
Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Jul 07
New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

May 06
Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

Earnings and Revenue Growth Forecasts

OM:BIOA B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,9239581,0298215
12/31/20261,227294-117-1125
12/31/20252,0161,0052,1232,1434
9/30/20251,9161,0001,0641,090N/A
6/30/20251,8601,0671,0251,051N/A
3/31/20251,517902-217-190N/A
12/31/2024257-177-343-316N/A
9/30/2024167-233-171-163N/A
6/30/2024299-88-142-134N/A
3/31/2024252-122-111-104N/A
12/31/2023616229302310N/A
9/30/2023607259113126N/A
6/30/2023617270284289N/A
3/31/2023619327294307N/A
12/31/2022229-11-44-32N/A
9/30/202223228-15-13N/A
6/30/202218-147-170-159N/A
3/31/202221-135-147-143N/A
12/31/202126-120-145-140N/A
9/30/202130-114-138-128N/A
6/30/202137-97-114-103N/A
3/31/202134-101-106-93N/A
12/31/202065-69-105-92N/A
9/30/202084-72-125-120N/A
6/30/202093-60-163-160N/A
3/31/202025278-46-43N/A
12/31/201928388324327N/A
9/30/2019779441286292N/A
6/30/2019852475N/A310N/A
3/31/2019729380N/A176N/A
12/31/2018722382N/A-200N/A
9/30/201825758N/A-157N/A
6/30/201819732N/A-149N/A
3/31/201819429N/A-139N/A
12/31/201715715N/A-135N/A
9/30/201719378N/A616N/A
6/30/201716071N/A630N/A
3/31/201712764N/A647N/A
12/31/201610658N/A675N/A
12/31/2015424N/A-16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOA B's earnings are forecast to decline over the next 3 years (-12.6% per year).

Earnings vs Market: BIOA B's earnings are forecast to decline over the next 3 years (-12.6% per year).

High Growth Earnings: BIOA B's earnings are forecast to decline over the next 3 years.

Revenue vs Market: BIOA B's revenue is expected to decline over the next 3 years (-4.4% per year).

High Growth Revenue: BIOA B's revenue is forecast to decline over the next 3 years (-4.4% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BIOA B's Return on Equity is forecast to be high in 3 years time (29.7%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/19 19:04
End of Day Share Price 2025/11/19 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioArctic AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrik LingDNB Carnegie
Kristofer Liljeberg-SvenssonDNB Carnegie
Rajan SharmaGoldman Sachs